HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

Abstract
The Public Health Laboratory Service receives antibiotic susceptibility data for bacteria from bloodstream infections from most hospitals in England and Wales. These data were used to ascertain resistance trends to ciprofloxacin from 1990 through 1999 for the most prevalent gram-negative agents: Escherichia coli, Klebsiella spp., Enterobacter spp., and Proteus mirabilis. Significant increases in resistance were observed for all four species groups. For E. coli, ciprofloxacin resistance rose from 0.8% in 1990 to 3.7% in 1999 and became widely scattered among reporting hospitals. The prevalence of resistance in Klebsiella spp. rose from 3.5% in 1990, to 9.5% in 1996 and 7.1% in 1999, while that in Enterobacter spp. rose from 2.1% in 1990 to 10.5% in 1996 and 10.9% in 1999. For both Klebsiella and Enterobacter spp., most resistance was localized in a few centers. Resistance was infrequent and scattered in P. mirabilis, but reached a prevalence of 3.3% in 1999.
AuthorsDavid M Livermore, Dorothy James, Mark Reacher, Catriona Graham, Thomas Nichols, Peter Stephens, Alan P Johnson, Robert C George
JournalEmerging infectious diseases (Emerg Infect Dis) Vol. 8 Issue 5 Pg. 473-8 (May 2002) ISSN: 1080-6040 [Print] United States
PMID11996681 (Publication Type: Journal Article)
Chemical References
  • Fluoroquinolones
  • Ciprofloxacin
Topics
  • Bacteremia (drug therapy, microbiology)
  • Ciprofloxacin (pharmacology, therapeutic use)
  • Drug Resistance, Bacterial
  • Drug Utilization
  • England (epidemiology)
  • Enterobacteriaceae (drug effects, physiology)
  • Enterobacteriaceae Infections (drug therapy, microbiology)
  • Fluoroquinolones (pharmacology, therapeutic use)
  • Humans
  • Practice Patterns, Physicians'
  • Wales (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: